DAVID GRAHAM to Clinical Trials as Topic
This is a "connection" page, showing publications DAVID GRAHAM has written about Clinical Trials as Topic.
Connection Strength
1.398
-
Illusions regarding Helicobacter pylori clinical trials and treatment guidelines. Gut. 2017 12; 66(12):2043-2046.
Score: 0.387
-
Editorial--Avoiding Unethical Helicobacter pylori Clinical Trials: Susceptibility-Based Studies and Probiotics as Adjuvants. Helicobacter. 2015 Oct; 20(5):321-5.
Score: 0.332
-
Helicobacter pylori eradication therapy research: Ethical issues and description of results. Clin Gastroenterol Hepatol. 2010 Dec; 8(12):1032-6.
Score: 0.236
-
Hp-normogram (normo-graham) for Assessing the Outcome of H. pylori Therapy: Effect of Resistance, Duration, and CYP2C19 Genotype. Helicobacter. 2016 Apr; 21(2):85-90.
Score: 0.085
-
Understanding and appreciating sequential therapy for Helicobacter pylori eradication. J Clin Gastroenterol. 2011 Apr; 45(4):309-13.
Score: 0.062
-
Efficient identification and evaluation of effective Helicobacter pylori therapies. Clin Gastroenterol Hepatol. 2009 Feb; 7(2):145-8.
Score: 0.052
-
Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. Drugs. 2008; 68(6):725-36.
Score: 0.049
-
Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users. Helicobacter. 2002 Feb; 7(1):1-8.
Score: 0.033
-
Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Am J Med. 2001 Jan 08; 110(1A):58S-61S.
Score: 0.030
-
Clarithromycin for Helicobacter pylori infection. Expert Opin Pharmacother. 2000 Mar; 1(3):507-14.
Score: 0.029
-
Update on Helicobacter pylori research. Eradication. Eur J Gastroenterol Hepatol. 1997 Jun; 9(6):626-8.
Score: 0.024
-
Sclerotherapy-associated esophageal ulcers: lessons from a double-blind, randomized comparison of sucralfate suspension versus placebo. Gastrointest Endosc. 1989 Jul-Aug; 35(4):312-5.
Score: 0.014
-
Gastroscopic localization of a microencapsulated KCl preparation in the human stomach. Gastrointest Endosc. 1987 Jun; 33(3):220-3.
Score: 0.012
-
Healing of benign gastric ulcer: comparison of cimetidine and placebo in the United States. Ann Intern Med. 1985 May; 102(5):573-6.
Score: 0.010
-
Double-blind comparison of liquid antacid and placebo in the treatment of symptomatic reflux esophagitis. Dig Dis Sci. 1983 Jun; 28(6):559-63.
Score: 0.009
-
Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology. 1982 May; 82(5 Pt 1):968-73.
Score: 0.008
-
Double-blind multicenter comparison of 1,200 mg. and 1,000 mg. cimetidine in hospitalized and ambulatory duodenal ulcer patients. Am J Gastroenterol. 1981 Dec; 76(6):500-5.
Score: 0.008
-
Limited value of early endoscopy in the management of acute upper gastrointestinal bleeding. Prospective controlled trial. Am J Surg. 1980 Aug; 140(2):284-90.
Score: 0.007
-
Antibacterial therapy for Crohn's disease: a review emphasizing therapy directed against mycobacteria. Dig Dis Sci. 2000 Mar; 45(3):445-56.
Score: 0.007
-
Suppression of nocturnal acid secretion with famotidine accelerates gastric ulcer healing. Gastroenterology. 1989 Oct; 97(4):860-6.
Score: 0.003